These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 20235800)
1. In vivo experimental approach to treatment against tabun poisoning. Berend S; Katalinić M; Vrdoljak AL; Kovarik Z; Kuca K; Radić B J Enzyme Inhib Med Chem; 2010 Aug; 25(4):531-6. PubMed ID: 20235800 [TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo evaluation of pyridinium oximes: mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity. Calić M; Vrdoljak AL; Radić B; Jelić D; Jun D; Kuca K; Kovarik Z Toxicology; 2006 Feb; 219(1-3):85-96. PubMed ID: 16332406 [TBL] [Abstract][Full Text] [Related]
3. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice. Kassa J; Karasova J; Musilek K; Kuca K Toxicology; 2008 Jan; 243(3):311-6. PubMed ID: 18054821 [TBL] [Abstract][Full Text] [Related]
4. The antidotal efficacy of the bispyridinium oximes K027 and TMB-4 against tabun poisoning in mice. Berend S; Radić B; Kuca K; Lucić Vrdoljak A Chem Biol Interact; 2010 Sep; 187(1-3):291-4. PubMed ID: 20138854 [TBL] [Abstract][Full Text] [Related]
5. Pretreatment with pyridinium oximes improves antidotal therapy against tabun poisoning. Lucić Vrdoljak A; Calić M; Radić B; Berend S; Jun D; Kuca K; Kovarik Z Toxicology; 2006 Nov; 228(1):41-50. PubMed ID: 16982122 [TBL] [Abstract][Full Text] [Related]
6. A comparison of the potency of newly developed oximes (K074, K075) and commonly used oximes (obidoxime, HI-6) to counteract tabun-induced neurotoxicity in rats. Kassa J; Karasova J Toxicology; 2007 Jan; 229(1-2):136-44. PubMed ID: 17141392 [TBL] [Abstract][Full Text] [Related]
7. New bispyridinium oximes: in vitro and in vivo evaluation of their biological efficiency in soman and tabun poisoning. Berend S; Vrdoljak AL; Radić B; Kuca K Chem Biol Interact; 2008 Sep; 175(1-3):413-6. PubMed ID: 18547553 [TBL] [Abstract][Full Text] [Related]
8. Oximes: Reactivators of phosphorylated acetylcholinesterase and antidotes in therapy against tabun poisoning. Kovarik Z; Calić M; Sinko G; Bosak A; Berend S; Vrdoljak AL; Radić B Chem Biol Interact; 2008 Sep; 175(1-3):173-9. PubMed ID: 18501341 [TBL] [Abstract][Full Text] [Related]
9. A comparison of reactivating and therapeutic efficacy of the oxime K203 and its fluorinated analog (KR-22836) with currently available oximes (obidoxime, trimedoxime, HI-6) against tabun in rats and mice. Kassa J; Karasova JZ; Caisberger F; Musilek K; Kuca K; Jung YS J Enzyme Inhib Med Chem; 2010 Aug; 25(4):480-4. PubMed ID: 20233085 [TBL] [Abstract][Full Text] [Related]
10. A comparison of the efficacy of new asymmetric bispyridinium oximes (K027, K048) with currently available oximes against tabun by in vivo methods. Kassa J; Kuca K; Cabal J; Paar M J Toxicol Environ Health A; 2006 Oct; 69(20):1875-82. PubMed ID: 16952906 [TBL] [Abstract][Full Text] [Related]
11. A comparison of reactivating and therapeutic efficacy of bispyridinium acetylcholinesterase reactivator KR-22934 with the oxime K203 and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice. Kassa J; Karasova JZ; Pavlikova R; Musilek K; Kuca K; Bajgar J; Jung YS Toxicol Mech Methods; 2011 Mar; 21(3):241-5. PubMed ID: 21142778 [TBL] [Abstract][Full Text] [Related]
12. A comparison of the reactivating and therapeutic efficacy of newly developed bispyridinium oximes (K250, K251) with commonly used oximes against tabun in rats and mice. Kassa J; Karasova J; Bajgar J; Kuca K; Musilek K; Kopelikova I J Enzyme Inhib Med Chem; 2009 Aug; 24(4):1040-4. PubMed ID: 19552519 [TBL] [Abstract][Full Text] [Related]
13. The evaluation of the neuroprotective effects of bispyridinium oximes in tabun-poisoned rats. Kassa J; Karasova J J Toxicol Environ Health A; 2007 Sep; 70(18):1556-67. PubMed ID: 17710615 [TBL] [Abstract][Full Text] [Related]
14. The influence of combinations of oximes on the reactivating and therapeutic efficacy of antidotal treatment of tabun poisoning in rats and mice. Kassa J; Karasova JZ; Pavlikova R; Misik J; Caisberger F; Bajgar J J Appl Toxicol; 2010 Mar; 30(2):120-4. PubMed ID: 19746406 [TBL] [Abstract][Full Text] [Related]
15. A comparison of the reactivating and therapeutic efficacy of two newly developed oximes (k727 and k733) with oxime k203 and trimedoxime in tabun-poisoned rats and mice. Kassa J; Sepsova V; Tumova M; Horova A; Musilek K Basic Clin Pharmacol Toxicol; 2015 Apr; 116(4):367-71. PubMed ID: 25225130 [TBL] [Abstract][Full Text] [Related]
16. A comparison of the potency of newly developed oximes (K027, K048) and commonly used oximes (obidoxime, HI-6) to counteract tabun-induced neurotoxicity in rats. Kassa J; Kunesova G J Appl Toxicol; 2006; 26(4):309-16. PubMed ID: 16552727 [TBL] [Abstract][Full Text] [Related]
17. The evaluation of the reactivating and therapeutic efficacy of two novel oximes (K361 and K378) in comparison with the oxime K203 and trimedoxime in tabun-poisoned rats and mice. Kassa J; Sepsova V; Tumova M; Musilek K; Horova A Toxicol Mech Methods; 2014 Mar; 24(3):173-8. PubMed ID: 24295433 [TBL] [Abstract][Full Text] [Related]
18. [Effect of acetylcholinesterase reactivator dosage on its effectiveness in the treatment of tabun poisoning in mice]. Kassa J Ceska Slov Farm; 2004 Jan; 53(1):31-4. PubMed ID: 15065394 [TBL] [Abstract][Full Text] [Related]
19. A comparison of the potency of newly developed oximes (K074, K075) and currently available oximes (obidoxime, trimedoxime, HI-6) to counteract acute toxic effects of tabun and cyclosarin in mice. Kassa J; Humlicek V Drug Chem Toxicol; 2008; 31(1):127-35. PubMed ID: 18161512 [TBL] [Abstract][Full Text] [Related]
20. The influence of combinations of oximes on the reactivating and therapeutic efficacy of antidotal treatment of soman poisoning in rats and mice. Kassa J; Karasova JZ; Caisberger F; Bajgar J Toxicol Mech Methods; 2009 Nov; 19(9):547-51. PubMed ID: 19839724 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]